Abdul Rehman – Trademark Portfolio
Entity Type: 01
Abdul Rehman has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate, with 2 applications currently pending. The portfolio includes marks such as QUIXAO and LIBEX PRODUCTS LLC. Filings span 5 Nice Classification classes, with the highest activity in Class 42 (Computer & Scientific) and Class 20 (Furniture). This trademark owner is based in Glendale Heights, IL.
441 Gregory Ave, Apt 1D
Glendale Heights, IL 60139
Showing of trademarks Trademarks
Trademark Classifications
Abdul Rehman's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Abdul Rehman have?
Abdul Rehman has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 1 abandoned.
What trademark classes does Abdul Rehman file in?
Abdul Rehman files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 20 (Furniture), Class 21 (Housewares), Class 5 (Pharmaceuticals), Class 28 (Toys & Sporting Goods). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Abdul Rehman's most well-known trademarks?
Abdul Rehman's registered trademark portfolio includes well-known marks such as QUIXAO and LIBEX PRODUCTS LLC. These are among 2 currently registered trademarks in the portfolio.
What is Abdul Rehman's trademark registration success rate?
Abdul Rehman has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.